stockrowAlto Neuroscience, Inc. (ANRO) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Alto Neuroscience, Inc. ANRO 25.16 +15.04%
- Syndax Pharmaceuticals, Inc. SNDX 9.54 +1.81%
Alto Neuroscience, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Alto Neuroscience, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($858.2M and $843.6M). Alto Neuroscience, Inc. has the higher net margin (0.00% vs −72.4%) and the higher return on invested capital (0.00% vs −83.4%). Across the 12 metrics below, Alto Neuroscience, Inc. leads on 9 and Syndax Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ANRO | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 92.21% | 68.51% |
| Operating margin | 0.00% | (61.72%) | 0.00% |
| Net margin | 0.00% | (72.38%) | 0.00% |
| Free cash flow margin | 0.00% | (61.36%) | 0.00% |
| Return on equity | (49.17%) | (426.43%) | (51.96%) |
| Return on assets | (40.90%) | (33.67%) | (46.06%) |
| Return on invested capital | 0.00% | (83.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack